Basic Information
Zysis is a pharmaceutical company dedicated to optimizing treatment solutions for central nervous system disorders, aiming to improve patients' lives. Zysis is currently developing two new therapeutic approaches. One is a once-weekly oral tablet for adjunctive treatment of psychiatric disorders or major depressive disorder (Aripiprazole Oral, Once Weekly). The other is a once-daily effective formulation for treating specific anxiety disorders, such as panic disorder and post-traumatic stress disorder (Nocturel).
Zysis Limited
England,United Kingdom
15~50 people
January 01, 2006
rp@zysis.com

